HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia

Park, Jong-Ho; Woo, Young Min; Youm, Emilia Moonkyung; Hamad, Nada; Won, Hong-Hee; Naka, Kazuhito; Park, Eun-Ju; Park, June-Hee; Kim, Hee-Jin; Kim, Sun-Hee; Kim, Hyeoung-Joon; Ahn, Jae Sook; Sohn, Sang Kyun; Moon, Joon Ho; Jung, Chul Won; Park, Silvia; Lipton, Jeffrey H.; Kimura, Shinya; Kim, Jong-Won; Kim, Dennis

期刊名称Leukemia
作者Park, Jong-Ho; Woo, Young Min; Youm, Emilia Moonkyung; Hamad, Nada; Won, Hong-Hee; Naka, Kazuhito; Park, Eun-Ju; Park, June-Hee; Kim, Hee-Jin; Kim, Sun-Hee; Kim, Hyeoung-Joon; Ahn, Jae Sook; Sohn, Sang Kyun; Moon, Joon Ho; Jung, Chul Won; Park, Silvia; Lipton, Jeffrey H.; Kimura, Shinya; Kim, Jong-Won; Kim, Dennis
印刷ISSN0887-6924
电子ISSN1476-5551
文件大小1661.39KB
发表时间2018-12-16
DOI10.1038/s41375-018-0321-8

发现好书期刊，享受阅读乐趣

HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia